For millions of Americans, GLP-1 medications like semaglutide and tirzepatide have reshaped the conversation around weight ...

Note: Compounded drugs are not approved by theU.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. In April 2025, the U.S. Food and Drug Administration ...

Hims & Hers, a telehealth startup, garnered attention and controversy by running a minute-long ad on weight loss medications during this year’s Superbowl. In the process, it created an opportunity for ...

Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...

Lab work is not included or required before starting medication, and there's little medical oversight.. SkinnyRx is a cash-pay telehealth platform that connects consumers with licensed clinicians to ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That's because a ...

Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers' Super Bowl ad plugs its compounded weight loss drugs as the "affordable" solution to a "sick system," but many ...

The US Food and Drug Administration (FDA) recently issued warning letters to more than 40 compounding pharmacies, demanding that they cease certain advertising practices for a variety of compounded ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...